Literature DB >> 25210008

The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).

Carolyn S P Lam1, Scott D Solomon.   

Abstract

Entities:  

Keywords:  Ejection fraction; heart failure

Mesh：

Substances：

Year:  2014        PMID： 25210008     DOI： 10.1002/ejhf.159

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  58 in total

Review 1.  Patient selection in heart failure with preserved ejection fraction clinical trials.

Authors:  Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

2.  Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.

Authors:  Xiaojing Chen; Gianluigi Savarese; Ulf Dahlström; Lars H Lund; Michael Fu
Journal:  Clin Res Cardiol       Date:  2019-04-12       Impact factor: 5.460

3.  Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.

Authors:  Ramachandran S Vasan; Vanessa Xanthakis; Asya Lyass; Charlotte Andersson; Connie Tsao; Susan Cheng; Jayashri Aragam; Emelia J Benjamin; Martin G Larson
Journal:  JACC Cardiovasc Imaging       Date:  2017-10-05

Review 4.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  Heart Failure with Mid-Range Ejection Fraction - a New Category of Heart Failure or Still a Gray Zone.

Authors:  Anca Andreea Andronic; Sorina Mihaila; Mircea Cinteza
Journal:  Maedica (Bucur)       Date:  2016-12

6.  Effects of glycemic control on in-hospital mortality among acute heart failure patients with reduced, mid-range, and preserved ejection fraction.

Authors:  Kenichi Matsushita; Kazumasa Harada; Tetsuro Miyazaki; Takamichi Miyamoto; Kiyoshi Iida; Shuzou Tanimoto; Mayuko Yagawa; Makoto Takei; Yuji Nagatomo; Toru Hosoda; Hideaki Yoshino; Takeshi Yamamoto; Ken Nagao; Morimasa Takayama
Journal:  Heart Vessels       Date:  2018-03-14       Impact factor: 2.037

7.  Mediterranean diet and prognosis of first-diagnosed Acute Coronary Syndrome patients according to heart failure phenotype: Hellenic Heart Failure Study.

Authors:  M Kouvari; C Chrysohoou; P Aggelopoulos; E Tsiamis; K Tsioufis; C Pitsavos; D Tousoulis
Journal:  Eur J Clin Nutr       Date:  2017-08-23       Impact factor: 4.016

8.  Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.

Authors:  Scott D Solomon; Brian Claggett; Eldrin F Lewis; Akshay Desai; Inder Anand; Nancy K Sweitzer; Eileen O'Meara; Sanjiv J Shah; Sonja McKinlay; Jerome L Fleg; George Sopko; Bertram Pitt; Marc A Pfeffer
Journal:  Eur Heart J       Date:  2015-09-15       Impact factor: 29.983

9.  The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis.

Authors:  Josip Anđelo Borovac; Katarina Novak; Josko Bozic; Duska Glavas
Journal:  Heart Vessels       Date:  2018-08-29       Impact factor: 2.037

Review 10.  Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.

Authors:  Annamaria Iorio; Andrea Pozzi; Michele Senni
Journal:  Curr Heart Fail Rep       Date:  2017-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.